Nazan Demir

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma.

|Sep 21, 2026
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.

|Sep 08, 2026
Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer.

|Aug 27, 2026
Prognostic Significance and Clinical Implications of the New FIGO 2023 Staging System in Patients with Endometrial Cancer.

|Oct 27, 2023
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer.

İvo Gökmen, Ebru Taştekin, Nazan Demir

Pageof 1

Frequent Collaborators

3 joint publications

Bahadır Köylü

2 joint publications

İvo Gökmen

2 joint publications

Ebru Taştekin

2 joint publications

Fatih Kemik